BG103123A - Steroid biphosphonates - Google Patents

Steroid biphosphonates

Info

Publication number
BG103123A
BG103123A BG103123A BG10312399A BG103123A BG 103123 A BG103123 A BG 103123A BG 103123 A BG103123 A BG 103123A BG 10312399 A BG10312399 A BG 10312399A BG 103123 A BG103123 A BG 103123A
Authority
BG
Bulgaria
Prior art keywords
steroid
group
osteal
biphosphonates
ostealimpairments
Prior art date
Application number
BG103123A
Other languages
Bulgarian (bg)
English (en)
Inventor
James Gallagher
Jonathan Moore
Wayne BOWLER
Philip PAGE
Original Assignee
The University Of Liverpool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The University Of Liverpool filed Critical The University Of Liverpool
Publication of BG103123A publication Critical patent/BG103123A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/548—Phosphates or phosphonates, e.g. bone-seeking

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BG103123A 1996-06-28 1999-01-27 Steroid biphosphonates BG103123A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9613722.9A GB9613722D0 (en) 1996-06-28 1996-06-28 Chemical compounds
PCT/GB1997/001748 WO1998000438A1 (en) 1996-06-28 1997-06-26 Steroid bisphosphonates

Publications (1)

Publication Number Publication Date
BG103123A true BG103123A (en) 1999-10-29

Family

ID=10796129

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103123A BG103123A (en) 1996-06-28 1999-01-27 Steroid biphosphonates

Country Status (23)

Country Link
US (1) US6140518A (zh)
EP (1) EP0912598A1 (zh)
JP (1) JP2000513372A (zh)
KR (1) KR20000022262A (zh)
CN (1) CN1226253A (zh)
AP (1) AP9801431A0 (zh)
AU (1) AU3350697A (zh)
BG (1) BG103123A (zh)
BR (1) BR9710074A (zh)
CA (1) CA2259309A1 (zh)
CZ (1) CZ432398A3 (zh)
EE (1) EE9800454A (zh)
GB (1) GB9613722D0 (zh)
HU (1) HUP9902880A3 (zh)
IL (1) IL127781A0 (zh)
IS (1) IS4931A (zh)
NO (1) NO986112L (zh)
PL (1) PL330781A1 (zh)
SK (1) SK175198A3 (zh)
TR (1) TR199900490T2 (zh)
WO (1) WO1998000438A1 (zh)
YU (1) YU59898A (zh)
ZA (1) ZA975749B (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7598246B2 (en) * 1998-04-02 2009-10-06 Mbc Pharma, Inc. Bisphosphonate conjugates and methods of making and using the same
US6896871B2 (en) 1998-04-02 2005-05-24 Mbc Research, Inc. Biphosphonate conjugates and methods of making and using the same
US8586781B2 (en) 1998-04-02 2013-11-19 Mbc Pharma, Inc. Bone targeted therapeutics and methods of making and using the same
TWI290144B (en) 1999-01-20 2007-11-21 Takara Bio Inc 4-substituded-3,6-anhydro-galactose derivatives and their pharmaceutical use
AUPQ232599A0 (en) * 1999-08-19 1999-09-09 Royal Alexandra Hospital For Children, The Drug for treating fractures
AU781068B2 (en) * 1999-08-19 2005-05-05 Sydney Children's Hospitals Network (Randwick and Westmead) (incorporating The Royal Alexandra Hospital for Children), The Drug for treating fractures
US6436386B1 (en) 2000-11-14 2002-08-20 Shearwater Corporation Hydroxyapatite-targeting poly (ethylene glycol) and related polymers
US7829074B2 (en) 2001-10-18 2010-11-09 Nektar Therapeutics Hydroxypatite-targeting poly(ethylene glycol) and related polymers
EP1383510B1 (en) * 2001-04-10 2012-10-17 MBC Pharma, Inc. Bisphosphonate conjugates and methods of making and using the same
WO2003099830A2 (en) * 2002-05-24 2003-12-04 Neopharm, Inc. Cardiolipin compositions, methods of preparation and use
EA200401565A1 (ru) * 2002-05-24 2005-04-28 Неофарм, Инк. Способ получения кардиолипина или аналога кардиолипина (варианты), способ получения липосомы и композиция кардиолипина для лечения заболеваний (варианты)
US20050277611A1 (en) * 2002-10-16 2005-12-15 Neopharm, Inc. Cationic cardiolipin analoges and its use thereof
US20060078560A1 (en) * 2003-06-23 2006-04-13 Neopharm, Inc. Method of inducing apoptosis and inhibiting cardiolipin synthesis
FI20070244A0 (fi) 2007-03-23 2007-03-23 Metso Paper Inc Tela
MX2010004400A (es) 2007-10-23 2010-05-20 Nektar Therapeutics Polimeros de multiples brazos dirigidos a la hidroxiapatita y conjugados de estos.
CA2843885C (en) 2011-08-01 2020-03-10 Mbc Pharma, Inc. Vitamin b6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates
KR20140064917A (ko) * 2011-08-31 2014-05-28 말린크로트 엘엘씨 H-포스포네이트-엔/-인 히드로포스포닐화 반응을 이용한 표적화된 나노입자의 원격 어셈블리
US10660884B2 (en) 2015-11-02 2020-05-26 University Of Rochester Phosphonate-chloroquine conjugates and methods using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4029499A1 (de) * 1990-09-18 1992-03-19 Boehringer Mannheim Gmbh Neue 17-(beta)-oestradiolderivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
EP0496520A1 (en) * 1991-01-22 1992-07-29 Merck & Co. Inc. Novel bone acting agents
FR2683527A1 (fr) * 1991-11-12 1993-05-14 Bretagne Occidentale Universit Prodrogues gem-bisphosphonates de sterouides derives de la cortisone.
JP3141053B2 (ja) * 1991-12-26 2001-03-05 アベンティス ファーマ株式会社 ビスホスホン酸誘導体
JP2746041B2 (ja) * 1992-02-14 1998-04-28 三菱化学株式会社 新規なステロイド誘導体

Also Published As

Publication number Publication date
PL330781A1 (en) 1999-06-07
HUP9902880A2 (hu) 2000-03-28
SK175198A3 (en) 1999-06-11
TR199900490T2 (xx) 1999-05-21
WO1998000438A1 (en) 1998-01-08
IS4931A (is) 1998-12-22
KR20000022262A (ko) 2000-04-25
CA2259309A1 (en) 1998-01-08
AP9801431A0 (en) 1998-12-31
AU3350697A (en) 1998-01-21
HUP9902880A3 (en) 2001-09-28
EE9800454A (et) 1999-06-15
NO986112D0 (no) 1998-12-23
EP0912598A1 (en) 1999-05-06
US6140518A (en) 2000-10-31
CN1226253A (zh) 1999-08-18
NO986112L (no) 1999-02-23
YU59898A (en) 1999-11-22
ZA975749B (en) 1998-07-27
GB9613722D0 (en) 1996-08-28
CZ432398A3 (cs) 1999-05-12
BR9710074A (pt) 2000-01-18
JP2000513372A (ja) 2000-10-10
IL127781A0 (en) 1999-10-28

Similar Documents

Publication Publication Date Title
BG103123A (en) Steroid biphosphonates
EP0611756A3 (en) Alcohol and aldehyde derivatives as an inhibitor of cathepsin L and as an inhibitor of bone resorption.
IL133891A (en) Valproenoic acid amide derivatives and pharmaceutical compositions containing them
CA2119363A1 (en) 10-desacetoxytaxol derivatives
DE69608904D1 (de) Nicht-steroidale sulfatase hemmer verbindungen
ZA976705B (en) Process for the synthesis of protected esters of (S)-3,4-dihydroxybutric acid.
IL135303A0 (en) Tricyclic triazolobenzazepine derivatives, process for producing the same and antiallergic agents
AU2439788A (en) Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition, processes for their preparation and compositions containing them
NZ324447A (en) 1-methyl-carbapenem substituted by a 4-pyrrolidinylthio group and medicaments
EP0755922A4 (en) 22-THIAVITAMIN D 3 DERIVATIVE
NO933885L (no) gsmåte
GB2276168A (en) Amine derivatives containing a phosphonic,phosphonous or phosphinic acid moiety
DE69318711D1 (de) Desferrioxamine-b salze und ihre verwendung als oral wirksame eisen- chelatbildner
EP0713873A3 (en) Aminocyclopentane derivative
AU3285000A (en) 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis
PL337691A1 (en) Novel derivatives of n-benzenosulphonyl-l-proline, method of obtaining them and pharmaceutic compositions containing such novel derivatives
DE69902782D1 (de) Substitutierte fünfgliedrige heterocyclische verbindungen, diese enthaltende fungizide zubereitungen und verfahren zur herstellung davon
DK0694029T3 (da) Fremgangsmåde til fremstilling af forbindelser afledt af beta-alkoxy-acrylsyre
CA2091829A1 (en) Cyclic aminomethylene bisphosphonate derivatives
GR3000337T3 (en) Organomagnesium compounds in solid form, process for their preparation and their use
UA66759C2 (en) Polyhydroxyphenol derivatives, medicinal compositions and a method for prevention and treatment of bone and cartilage diseases
EP0169725A3 (en) New method of treatment using prostaglandin analogues
EP0791581A4 (en) UCH 15 STRAIN COMPOUNDS
YU57800A (sh) Preventivno i terapeutsko sredstvo za kost i hrskavicu koje sadrži derivat barbiturne kiseline
MX9801926A (es) Procedimiento para la preparacion de derivados de arilalquinil-n-hidroxiurea que tienen actividad inhibidora de lipoxigenasa.